BRIEF:
Small Pharma, is an innovative neuropharma company exploring the use of psychedelics for ground-breaking treatment of depression. When they were granted the world’s first licence for clinical trials of their DMT molecule construct, we were tasked with raising awareness of the company.
SOLUTION:
Mental Health Awareness Week 2021 was an important opportunity to position Small Pharma as a key player in the development of innovative treatments for depression. We persuaded long time mental health campaigner and openly ‘depressive’ Alastair Campbell to ‘interrogate’ Small Pharma about why they believe their psychedelic drug DMT, could be the answer.
RESULTS:
The result was extensive national media coverage, including The Telegraph and The i. Further millions were reached via Alastair sharing posts on Twitter and Instagram resulting in Small Pharma’s social channels registering 160K impressions and a jump of 3,000 visitors to their website.
